Skip to content

Monopar Therapeutics MNPR FX Effect on Cash

FX Effect on Cash at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$48M-173%
Eli Lilly logo
Eli LillyLLY
$67M-49.2%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$4M-119%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1M-200%
Wave Life Sciences logo
Wave Life SciencesWVE
-$4K-107%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-$111K-156%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M-62.2%
Net income-$3.9M-48.3%
EPS (diluted)-$0.19

Balance sheet

See full
Cash & equivalents$52.5M+32.3%
Total debt$230.4K+2,692%
Total equity$135.4M+153%
Total assets$138.0M+150%

Cash flow

See full
Operating cash flow-$3.5M+38.7%

Valuation

See full
Market cap$587.04M+192%
Enterprise value$534.72M+232%

Returns & leverage

See full
Return on equity-15.9%-6.6pp
Debt / equity0.0×
Current ratio56×

Where this comes from

Reported directly by Monopar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Monopar Therapeutics's FX effect on cash?
Monopar Therapeutics (MNPR) reported FX effect on cash of -$31.63K in Q1 2026.
How has Monopar Therapeutics's FX effect on cash changed year-over-year?
Monopar Therapeutics's FX effect on cash decreased by 58470.4% year-over-year, from -$54 to -$31.63K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.